Results 211 to 220 of about 113,461 (351)

Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments. [PDF]

open access: yesBiomedicines
Galue-Parra AJ   +4 more
europepmc   +1 more source

Diabetes and Obesity Modify the Effect of Alcohol Consumption on Carbohydrate‐Deficient Transferrin

open access: yesEndocrinology, Diabetes &Metabolism, Volume 8, Issue 6, November 2025.
There is an interaction between alcohol consumption and factors associated with insulin resistance in relation to transferrin sialylation. The sensitivity of carbohydrate‐deficient transferrin for detecting heavy alcohol consumption might be limited in patients with obesity or diabetes.
Tomás González‐Vidal   +7 more
wiley   +1 more source

Tumor desialylation surpasses anti‐PD‐L1 checkpoint therapy in restoring anti‐tumor immunity in a murine model for colorectal cancer

open access: yesInternational Journal of Cancer, Volume 157, Issue 9, Page 1948-1962, 1 November 2025.
What's new? Our research highlights how tumor sialylation affects tumor growth and reshapes the immune tumor microenvironment in colorectal cancer. We demonstrate for the first time that complete removal of sialic acids from colorectal tumor cells elicits a robust anti‐tumor immune response, but does not enhance anti‐PD‐L1 blockade efficacy.
Irene van der Haar Àvila   +11 more
wiley   +1 more source

Trial Readiness: Understanding the Natural History of Rare Diseases

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Inherited metabolic diseases (IMD) represent the largest and still growing group of treatable genetic disorders and are increasingly amenable to targeted interventions that achieve varying degrees of prognostic improvement. Innovative therapies are on the horizon and offer promising opportunities for disease‐changing treatment for a variety of
Thomas Opladen   +6 more
wiley   +1 more source

Quantitative analysis of inhibitor‐induced assembly disruption in human UDP‐GlcNAc 2‐epimerase using mass photometry

open access: yesProtein Science, Volume 34, Issue 11, November 2025.
Abstract Uridine diphosphate N‐acetylglucosamine (UDP‐GlcNAc) 2‐epimerase (GNE)/N‐acetylmannosamine kinase is the rate‐limiting enzyme in sialic acid biosynthesis and a promising therapeutic target. We applied mass photometry (MP) to investigate GNE oligomerization and its modulation by three small‐molecule inhibitors (C5, C13, and C15).
Nico Boback   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy